Biotech and Pharmaceutical Industry Events & Conferences

Summary

Join us for SMi's 6th annual Accelerating Patient Recruitment & Retention in Clinical Trials. Delve into the latest developments in patient recruitment and retention and learn how the Internet and social media can be utilised to enhance your recruitment and retention with interactive sessions aimed at voicing multiple points of view and experiences.

 

Patient recruitment and retention are critical to drug development programs. Patient recruitment if not adequately planned for can extend development time-lines by a number of years. Retention of patients throughout the life of a clinical trial is essential in order have complete data sets for analysis and subsequent filings.

 

Patient recruitment now takes up 23% of the total clinical trial timeline and, worryingly, this percentage is rising. The industry needs a front-line assessment of how things work in the physician's office, what motivates patients, how pharmaceutical service providers perform, and data on the most effective techniques for patient recruitment and retention; this conference aims to deliver just that.

 

Click here to register online and save £100: http://www.smi-online.co.uk/2010patientrecruit9.asp

Alternativly contact Daniel Davies Tel. +44 (0) 20 7827 6060

Or e-mail: ddavies@smi-online.co.uk

Remember to quote “Report Buyer” and Save £100

 

 

 

For more information visit: http://www.smi-online.co.uk/2010patientrecruit9.asp

Summary

Today, more than ever before, supply chain managers must focus on cost-cutting, outsourcing logistics, improving customer service along the supply chain, improving supply chain agility, safety and visibility, all while remaining compliant with changing regulations.

 

In its 9th year, LogiPharma is the event that most senior level pharmaceutical decision makers attend and here is why:

-          You will be able to gain real life practical applications from 20+ NEW Speakers,  25+ NEW Case Studies

-          Network with industry peers with Roundtable Discussions on key industry initiatives

-          Take a deep dive with a Focus Day on Improving Supply Chain Agility

-          Dig deep with 4 Interactive Workshops

-          Be the first to hear the results of the EFPIA pilot results to understand serialization proposal and determine timeline for implementation

-          Examine a FRESH Case Study from Sandoz Turkey, the first country in the world to mandate serialization of pharma products!

 

Join over 200 supply chain Heads and Directors from leading pharma companies like Pfizer, Bristol-Myers Squibb, Amgen, UCB, and Teva who attend this event every year!

 

For more information: download the brochure on www.logipharmaeurope.com, call +44 (0)207 368 9465 or email info@wbr.co.uk.

For more information visit: http://www.logipharmaeurope.com

Summary

The market opportunities for cancer treatments are at an all-time high but the publication rate of clinical trials is low due to factors such as flawed design and failure to meet endpoints. SMi's 9th annual Clinical Trials in Cancer conference will feature presentations from industry professionals and academic experts on how to manage clinical development in this crucial therapeutic area.

This year's expert speaker line-up includes:

·         Mike Lau, Principal Clinical Development Scientist, Oncology, GlaxoSmithKline

·         Giacomo Mordenti, Senior Biostatistician, Global Biostatistics, Merck Serono

·         Jenny Gray, Industry Lead, National Cancer Research Network

·         Francesca Duchesne, Manager, INDOX Cancer Research Network, University of Oxford

·         Iman El-Hariry, Global Head of Oncology, Astellas Pharma

·         Ian Walker, Licensing Manager, Clinical Partnerships, Cancer Research Technology

·         Benedikte Thunes Akre, Medical Science Manager, Oncology and Haematology, Bristol-Myers Squibb 

·         Ridwaan Jhetam, Head of Global Clinical Operations and Oncology director, Johnson & Johnson

To view the full impressive speaker line-up please visit our website at: www.smi-online.co.uk/2010ctcancer.asp

Key topics to be discussed at this year's event include:

·         Targeted cancer therapies in personalised medicine

·         Site selection and new approaches to data collection

·         Regulatory requirements for adaptive designs

·         Epidermal growth factor receptor inhibitors

·         Novel transcriptomic-based biomarkers

Plus an associated half day post conference workshop

Challenging times – Designing Early Phase Oncology Trials in association with SMS Oncology
Wednesday 7^th July, 8.30am – 1.30pm, Crowne Plaza St James Hotel, London

 

For more information visit: http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3260

Summary

Taking place in London, this event will look at a wide range of issues within the pain therapeutics arena.  It will combine a study of the latest successes in the research and development phase with presentations covering the key themes of biomarkers and the cannabinoid approach.

Attend this conference and:

·         Hear from some of the most important and influential experts working in pain therapeutics

·         Learn about the challenges of early drug development

·         Study the latest targets and compounds being researched

·         Network with people you need to know in the pain therapeutics world

This year's keynote addresses will include:

·         Chas Bountra, Chief Scientist, Structural Genomics Consortium, University of Oxford

·         Linda Surh, Director, Drug Discovery Global Regulatory Affairs, GlaxoSmithKline

·         José Miguel Vela, Basic Research & Drug Discovery, Esteve

·         Sharon Bingham, In Vivo Pharmacology & Translational Science, GlaxoSmithKline

·         Jane Hughes, Associate Director, Neuroscience, Medimmune

·         Steve England, Associate Research Fellow, Pfizer

·         Lars Arendt-Nielsen, Director, Centre for Sensory-Motor Interaction, Aalborg University

 

PLUS associated post conference workshop

Translation from Model to Man and Back in association with AstraZeneca

9th June 2010, Crowne Plaza - The City
This workshop will address the gap between discovery and development and the translational tools used to bridge that gap.

For more information visit: http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3248

Summary

SMi's 5th Annual Pharmaceutical Portfolio & Product Life Cycle Management Conference will provide an unmissable learning and networking opportunity with the leading experts from the world of Portfolio and Life Cycle Management.

Offering you exceptional insight into: 

·          Improving accuracy in tracking and managing pharmaceutical projects

·          Cutting the costs of developing new products

·          The latest developments and issues in the regulatory landscape

·          Optimisation of portfolio planning and project scheduling

·          Route to efficient resource allocation

·          Defining and planning major operational projects

Book today and receive £300 off your delegate place offer end the 31^st March 2010.

Chairing the Conference:

Tony Ellery, President, Ellery Pharma Consulting
(Former Global Head LCM in Portfolio Management, Novartis)  

 

This year's speaker line-up also includes:

 

Kimber Hardy, Head of Valuation and Analysis, Merck Serono

Harrald Nusser, VP Portfolio Management, Strategic Planning, Bayer Health Care

John Bird, Director Portfolio Management, UCB

Michael O'Grady, Portfolio-Analysis Manager GSK

Martin Husebø, Global Portfolio Manager, Novo Nordisk 

Marie Bernasconi, Global Program Team Director, Novartis

Peter Elsig Raun, Head of Department - Branded Products, H. Lundbeck

Roger Holdsworth, Director - R&D Portfolio Management, UCB

William Haddad, Chairman & CEO, Biogenerics

Pasi Piitulainen, Senior Director, Business & Science Affairs, Actelion Pharmaceuticals

 

For more information visit: http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3257

Summary

We are pleased to present you with our 2^nd annual KOL Europe conference.  Following the success of the last year's conference, this event has returned with a strong and interesting line up of speakers with a new take on the KOL debate. 

 

The role of a Key Opinion Leader should extend far beyond product approval. Relationships between KOLs and pharma companies work best when the KOL provides input into all stages of drug development.

 

SMi's 2nd annual KOL Europe conference will feature presentations from actual KOLs and senior industry professionals with extensive experience of managing scientific relationships. Attend and gain a new perspective on the role of KOLs and explore new ways of using them to achieve successful drug development and marketing strategies. 

 

Hot Topics at this year's Conference:

 

• The new wave of independent KOLs
• The role of public authorities in legislating the use of KOLs
• Long-term KOL relationships and ensuring transparency
• Opinion Leader management Strategy and its role in marketing

 

Speakers include:

 

• Thomas D. Szucs, Chairman, European Centre of Pharmaceutical Medicine
• Andy Powrie-Smith, Director, Association of the British Pharmaceutical Industry
• Gunnar Schroefel, Global Business Support Manager, Bayer Healthcare
• Axel Glasmacher, European Head of Medical Affairs, Celgene Internationanal
• Karen Langfeld, Global Professional Relations Manager, AstraZeneca
• Lurdes Reis, Scientific Communication Manager, Bayer Schering Pharma
• Raimund Sterz, Medical Director, Global Health Economics and Outcomes Research,  Abbott
• Phillipe Fonjallaz, Program Partner, Scientific Relations, Merck Serono
• Michal Konstacky, Global Medical Affairs Director, Solvay Pharmaceuticals
• Ardeschir Ghofrani, Head of Pulmonary Hypertension Division, University Hospital Giessen und Marburg

Remember to quote “Report Buyer” and Save £100

For more information visit: http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3251

Summary

Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) screening is crucial to the drug development process and assists the elimination rate of weak drug candidates early in the drug-discovery process, and decreases the proportion of compounds failing in clinical trials for ADMET reasons. SMi's 5th Annual ADMET Conference will bring you up to date with the latest developments, technologies and techniques that are in use across the industry and look towards the future.
This meeting will feature talks from experts who will address topics including:

·         ADMET and PK/PD modelling in drug discovery and development

·         Innovative ADME models

·         ADME optimisation in early- and late-phase drug discovery

·         Drug-drug interaction prediction

·         Drug transporter assays

·         Predictive toxicology model development

·         Emerging in vitro and in vivo toxicity assays

·         Metabolism based toxicity

  Plus a half-day post-conference workshop:

Current Perspectives and Approaches on the Application of Computational Modelling in PK, PK/PD and Toxicity Prediction

 9^th July 2010, Crowne Plaza St James Hotel, London, UK

Hosted by Barry Hardy, Director, Douglas Connect

 

For more details contact Zain Philbey on +44 (0) 20 7827 6722 or Email : zphilbey@smi-online.co.uk

Quote Report Buyer and save £100

For more information visit: http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3261

Summary

SMi's 2nd annual In Vitro Diagnostics will provide an integral forum to leaders in biotech, pharma and labs to discuss the value of diagnostics and overcome challenges posed by regulatory bodies. Make sure you attend this event and walk away with all the essential knowledge needed to maximise the potential, profitability and sustainability of your business.

Key Speakers Include:

·         Ansar Jawaid, Global Diagnostics Manager, ASTRAZENECA

·         Dr Said El Mouatassim, Head of Molecular Biology, BIOMNIS SPECIALISED MEDICAL PATHOLOGY

·         Vicki Petrides, Statistician Section Head, Diagnostics Division, ABBOTT DIAGNOSTICS

·         Elaine Mooney, Scientific Officer IVD, IRISH MEDICINES BOARD

·         Anil Modak, Associate Director, Medical Products Research & Development, CAMBRIDGE ISOTOPE LABORATORIES

·         Dr Rob Elles, Director of Molecular Genetics, MANCHESTER ACADEMIC HEALTH SCIENCE CENTRE, ST MARY'S HOSPITAL

Key Topics Include:

·         Delivering on the promise of personalised healthcare

·         Understanding the role and impact of new technologies in point of care testing

·         Molecular tests for drug resistance and genotyping

·         Opportunities for new biochip technology in laboratory & point of care testing

·         IVD industry guidelines, study design and analysis considerations

Click here to register online and save £100:  http://www.smi-online.co.uk/2010ivd9.asp

Alternatively contact Lee Gillon on tel: +44 (0)20 7827 6104

or Email : lgillon@smi-online.co.uk

Remember to quote “Report Buyer” and Save £100

For more information visit: http://www.smi-online.co.uk/2010ivd9.asp